TipRanks
Go Ultimate55% OFF

Shanrong Biotechnology (SRBT) Financial Statements

Shanrong Biotechnology Financial Overview

Shanrong Biotechnology's market cap is currently $102.55K. The company's EPS TTM is $-0.23; its P/E ratio is -0.00; Shanrong Biotechnology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 22Dec 17
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -78.99K$ -31.75K
EBITDA$ -78.99K$ -31.75K
Net Income$ -78.98K$ -31.75K
Balance Sheet
Cash & Short-Term Investments$ 18.30K$ 24.78K
Total Assets$ 18.30K$ 24.78K
Total Debt$ 0.00$ 0.00
Net Debt$ -18.30K$ -24.78K
Total Liabilities$ 97.28K$ 63.99K
Stockholders' Equity$ -76.98K$ -39.21K
Cash Flow
Free Cash Flow$ -77.17K$ -31.75K
Operating Cash Flow$ -77.17K$ -31.75K
Investing Cash Flow$ 0.00$ 0.00
Financing Cash Flow$ 95.47K$ 56.53K

Currency in USD

Shanrong Biotechnology Earnings and Revenue History

-90K-60K-30K00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172022RevenueEarningsProfit Margin

Shanrong Biotechnology Debt to Assets

040K80K120K240 %360 %480 %600 %LiabilitiesDebt to Assets20172022AssetsLiabilitiesDebt to Assets

Shanrong Biotechnology Cash Flow

-100K-50K050K100K150K20172022OperatingInvestingFinancing

Shanrong Biotechnology Forecast EPS vs Actual EPS